Cancer's Clues

In a Business Report: The [San Francisco] Chronicle with Bloomberg post, John Lauerman says that "using faster, more accurate technologies, doctors are combing through ever-wider swaths of the human genome to pinpoint and counteract the causes of disease." According to the Dana-Farber Cancer Institute's Barrett Rollins, "cancer is among the most promising targets." Rollins tells Lauerman that genome screens are quickly becoming st

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.